Prospective Randomised Investigation of the Safety and Efficacy of Micardis® vs Ramipril Using ABPM
Status:
Completed
Trial end date:
2003-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to demonstrate that telmisartan 80 mg (MICARDIS®) is
at least as effective and possibly superior to ramipril 5mg and 10mg in lowering mean
ambulatory diastolic blood pressure (DBP) and systolic blood pressure (SBP) during the last 6
hours of the 24-hour dosing interval in mild-to-moderate hypertensive patients at the end of
an 8 and 14-week treatment period, respectively.